Access to breast-conserving therapy still an issue for some patients
the ONA take:
According to a new study published in JAMA Surgery, researchers at The University of Texas MD Anderson Cancer Center in Houston, Texas, have found that the rates of breast-conserving therapy for early-stage breast cancer have increased, but access to this treatment modality still remains an issue for some patients.
For the study, researchers analyzed data from approximately 728,000 women with stage T1 or T2 breast cancer treated between 1998 and 2011 from the National Cancer Data Base. Researchers found that the proportion of patients undergoing breast-conserving therapy increased from 54.3% in 1998 to 59.7% in 2006, and leveled off at 60.1% in 2011.
Results showed that certain demographic factors, such as insurance, income, and travel distance to treatment facilities, impact which patients have access to breast-conserving therapy; however, declines in disparities related to age, geographic region, and treatment facility type were also observed.
The findings suggest that the majority of women are opting for breast-conserving therapy, but various disparities still exist that limit access to that treatment approach.
Rates of breast-conserving therapy for early-stage breast cancer have increased.
Sign Up for Free e-newsletters
- Scalp Cooling With Dignicap May Reduce Alopecia During Chemotherapy for Breast Cancer
- Evolution of HER2-Positive Breast Cancer: Yesterday, Today, and Tomorrow
- Dedicated End-of-Life Education Program Improves Nurses' Care, Patient and Family Satisfaction
- Reflexology, Aromatherapy May Reduce Pain, Anxiety of Brachytherapy for Cervical Cancer
- Oncology Extended Care Clinic Reduced Urgent Cancer-Related ED Visits
- Hair Dyes and Cancer Risk (Fact Sheet)
- Taste Changes After Hematopoietic Stem Cell Transplant Affect QOL in Blood Cancers
- Hope, Optimism Reduce Psychological Distress in Advanced Cancer
- Mitomycin Extravasation Protocol
- Accurate Understanding of Capacity May Improve Workflow, Efficiency in Infusion Suite
- Nursing Practice Change Improved Chemo Administration, But Old Habits Die Hard
- Simple Adjustment Key to Paclitaxel Infusion Protocol That Reduced Hypersensitivity Reactions
- Online Program Aims to Assist With Clinical Trial Enrollment for Hematologic Cancers
- Education May Better Equip Nurses to Hold End-of-Life Conversations in Advanced Cancer
- Skipping the SICU Post Head and Neck Cancer Surgery May Improve Outcomes
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|